Press Releases

February 2, 2024
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 11, 2024
Praxis Precision Medicines, Inc. Announces Pricing of $150.0 Million Public Offering
January 8, 2024
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
January 5, 2024
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China